MiR-622 functions as a tumor suppressor and directly targets E2F1 in human esophageal squamous cell carcinoma - 21/10/16
, Zhigang Wang c, ⁎ Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 7 |
| Iconographies | 4 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Purpose |
MicroRNA-622 has been proven down-regulated in many human malignancies and correlated with tumor progression. However, its role in esophageal squamous cell carcinoma (ESCC) is still unclear. The aim of this study was to explore the expression and function of miR-622 in ESCC.
Methods |
Using quantitative RT-PCR, we detected miR-622 expression in ESCC cell lines and primary tumor tissues. The association of miR-622 expression with clinicopathological factors and prognosis was also analyzed. Then, the effects of miR-622 on the biological behavior of ESCC cells were investigated. At last, the potential regulatory function of miR-622 on E2F1 expression was confirmed.
Results |
miR-622 was found to be down-regulated in ESCC tissues and cell lines. Decreased miR-622 expression was closely correlated with aggressive clinicopathological features and poor overall survival. Multivariate regression analysis corroborated that low level of miR-622 expression was an independent unfavourable prognostic factor for patients with ESCC. Up-regulation of miR-622 could significantly reduce ESCC cell proliferation, enhance cell apoptosis, and impair cell invasion and migration in vitro, while down-regulation of miR-622 showed opposite effects. Further, E2F1 was confirmed as a direct target of miR-622 by using Luciferase Reporter Assay.
Conclusions |
These findings indicate that miR-622 may act as a tumor suppressor in ESCC and would serve as a potential therapy target for this disease.
Le texte complet de cet article est disponible en PDF.Keywords : MiR-622, Esophageal squamous cell carcinoma, E2F1, Prognosis, Proliferation, Apoptosis
Plan
Vol 83
P. 843-849 - octobre 2016 Retour au numéro
Article précédent
- The Urtica dioica extract enhances sensitivity of paclitaxel drug to MDA-MB-468 breast cancer cells
- Ali Mohammadi, Behzad Mansoori, Mahyar Aghapour, Solmaz Shirjang, Sanam Nami, Behzad Baradaran
- MiR-139-3p induces cell apoptosis and inhibits metastasis of cervical cancer by targeting NOB1
- Ping Huang, Jie Xi, Shikai Liu
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?